Abstract
Smoking behavior has been well-established to be more prevalent in individuals with psychosis and bipolar disorder compared to the general population. However, reports about higher suicide attempt prevalence of smoking compared to non-smoking patients suggest that smoking behavior may contribute to identifying at-risk groups of patients in a comparatively easy manner. In the present systematic quantitative review, we provide meta-analytical evidence on the smoking and suicide attempt link in 22 studies (k = 27 independent samples; N = 11,452) of patients with psychosis and bipolar disorder. We observed a small meaningful effect of smoking on suicide attempts (OR = 1.70; 95% CI [1.48; 1.95]), indicating that smokers have 1.70 the odds of having reported a suicide attempt compared to non-smokers. This effect generalized across diagnosis type (i.e., schizophrenia vs. bipolar spectrum disorder), sample type (i.e., in-vs. outpatients), and participant sex. However, the observed summary effect appeared somewhat inflated due to publication process-related mechanisms, showing some evidence for effect-inflating publication bias and a decline effect. In all, the presently observed smoking and suicide attempt link appears to be small but meaningful and robust, thus suggesting smoking status represents a useful variable for the identification of at-risk populations for suicide attempts.
1 Introduction
It has been well-established that people who have been diagnosed with mental illnesses have elevated smoking rates (Hartz et al., 2014). For instance, psychotic patients have been reported to show a smoking prevalence that is more than twice as large compared to that of the general population (Dickerson et al., 2013). However, individuals with psychosis are not only more likely to smoke but also to consume more, stronger, and often unfiltered cigarettes (and therefore more laden with nicotine and tar) (de Beaurepaire et al., 2012). Moreover, they have been reported to have more difficulty quitting than other individuals (Haustein et al., 2002).
Several candidate theories have been proposed that may explain the smoking prevalence differences between healthy adults and individuals diagnosed with psychosis and bipolar disorder. Arguably, the most prominent theory is currently the self-medication theory (Isuru and Rajasuriya, 2019), which postulates that psychotic and bipolar patients typically show predating substance abuse (i.e., before the onset of the mental condition), a more substantial nicotine addiction than general population samples, and an ongoing benefit (e.g., counteracting medical side effects, improving cognition) regarding nicotine consumption (Kumari and Postma, 2005). Other potential explanations postulate a shared diathesis (e.g., higher risk of developing mental illnesses and nicotine dependence due to shared genetic risk factors) between smoking and psychosis (Khokhar et al., 2018) or a unidirectional causal influence of nicotine on the development of mental illness (Gurillo et al., 2015).
For individuals with psychosis and bipolar disorders, both smoking and previous suicide attempts have been suggested to represent risk factors that put them at a considerably higher risk for suicide than the general population (Cassidy et al., 2018; Pompili et al., 2013). The self-medication theory posits that problem-solving difficulties in people diagnosed with psychosis and bipolar disorder, which include emotional processing, social clue perception, attributional style, theory of mind, and the sharing, understanding, and response to others’ emotions (Bora et al., 2009; Green et al., 2015; Savla et al., 2013), could be alleviated through the activation of nicotinic acetylcholine receptors by tobacco in the cerebral cortex area (Gil and Metherate, 2019). On the one hand, smoking seems to improve cognitive functions, such as problem-solving and attention (Knapp et al., 2017; Lee and Van Meter, 2020; Martin and Sayette, 2018; Miskowiak et al., 2019). On the other hand, these beneficial effects are comparatively short-lived, and improvements fade quickly.
Consistent with this idea, some studies have shown that suicide risk appears to be elevated in smokers with psychosis and bipolar disorder. Previous meta-analytical accounts on the smoking and suicide ideation link suggested positive associations in the general population (e.g., Sankaranarayanan et al., 2015) as well as in individuals with psychosis (Pietschnig et al., 2019). In fact, (i) seemingly similar patterns of the smoking and suicidality link that have been reported in past studies for both patients with psychosis and bipolar disorders as well as (ii) common proposed candidate mechanisms that these patterns are rooted in may be interpreted as evidence for potentially similar associations between smoking and suicidality in these patient groups.
However, the strength and meaningfulness of this effect in patients with psychosis and bipolar disorder remains to date unclear. Low sample numbers and indications of potentially confounding effects of dissemination bias in a previous meta-analysis on this topic (Sankaranarayanan et al., 2015), as well as the decline effect (i.e., a larger likelihood of effect strengths to decrease rather than to increase over time, e.g., Pietschnig et al., 2019), warrant an update of the existing evidence. In the present systematic review, we examine all available evidence of the smoking and suicidality link in individuals diagnosed with psychosis and bipolar disorder while accounting for potential influences of dissemination bias.
2 Methods
The present study was preregistered prior to accessing the data. The preregistration protocol, deviations from the preregistration, and PRISMA Checklist are available on the Open Science Framework (OSF; https://osf.io/j69dk and https://osf.io/yxn2k/).
2.1 Literature search
The literature search was concluded in January 2024. We searched five databases for eligible published studies (ISI Web of Science, PubMed, PsychINFO, CINAHL, and Scopus). Furthermore, the Open Access Dissertation and Theses database (oadt.org) was searched for grey literature. We used the following search string: (“smok* OR “nicotine”) AND (“suicide*” OR “suicide attempt”) AND (“psychosis” OR “psychotic” OR “bipolar” OR “schizophren*”). In August 2024, the literature search was updated and the search string was extended to include the search term “tobacco use.”
2.2 Inclusion criteria
To be included in the present meta-analysis, studies had to meet seven inclusion criteria. They had to (i) be observational, (ii) provide an odds ratio or sufficient statistical parameters to calculate one for smoking and suicide attempts, (iii) include lifetime or past year reports of suicide attempts, (iv) report the respective sample size, (v) report data of people with psychotic disorders (i.e., schizophrenia, schizoaffective disorder, first-episode psychosis, delusional disorder, bipolar disorder, or psychotic depression), (vi) comprise adult participants (mean sample age = 18 years+), and (vii) be published in English. In all, 3,603 study titles and abstracts were screened after duplicate removal (see Figure 1 for a PRISMA flow chart). Study coding was conducted twice independently by one researcher. Discrepancies were resolved by discussion with another independent and experienced researcher. All data are provided on the OSF.1
Figure 1
2.3 Data extraction and coding
We coded event vs. non-event data (i.e., numbers of smokers and non-smokers who did or did not attempt suicide) into categories and recorded study-specific variables: Study type (cohort vs. cross-sectional vs. case–control); sample type (inpatients vs. outpatients vs. mixed); diagnosis type (schizophrenia spectrum vs. bipolar spectrum vs. mixed; of note, a further differentiation according to type of diagnosis was not feasible due to low study cell counts in terms of reported diagnoses); sample size; country of publication. In cases of missing information, data were requested from corresponding authors by email. If no responses were received, individual entries were coded as missing.
2.4 Primary study quality assessment
We used the Newcastle-Ottawa Quality Assessment Scale (Wells et al., 2021) to assess study quality regarding risk of bias assessments according to an adapted approach for cross-sectional studies (Dürlinger and Pietschnig, 2022). Primary study quality was assessed by an experienced researcher [J.P.] and rated according to four criteria (ratings are provided at https://osf.io/brzs4). Rating sum scores were subsequently correlated with primary study effect sizes to assess potential influences of study quality on effect size estimation. No statistically significant influences of primary study quality ratings on effect estimation were identified in the present study in a precision-weighted meta-regression (Q = 1.78; p = 0.182).
2.5 Statistical analyses
We used random-effects models to calculate summary effects. For our calculations, odds ratios were transformed into log odds ratios and, after analysis, back-transformed for ease of interpretation. All analyses were conducted with the open source software R 4.10 (R Core Team, 2023) [packages: metafor (Viechtbauer, 2010), data.table (Dowle et al., 2019), esc (Lüdecke et al., 2019), puniform (van Aert et al., 2020), readxl (Wickham et al., 2019), tidyverse (Wickham and Wickham, 2017), and weightr (Coburn et al., 2019)]. Between-studies heterogeneity was interpreted according to well-established thresholds of the I2-index [i.e., 25, 50, and 75% representing lower thresholds of small, moderate, and large heterogeneity, respectively; (Higgins et al., 2003)]. Following well-established benchmarks, Odds Ratios of 1.44, 2.48, and 4.27 (corresponding to logOR = 0.36, 0.91, and 1.45, respectively) were interpreted as the lower thresholds of small, medium, and large effects (Cohen, 1988).
2.6 Moderator analyses
We used mixed-effects subgroup analyses to assess potential influences of categorical moderators, specifically, diagnosis type (bipolar vs. schizophrenia vs. mixed), sample type (inpatients vs. outpatients vs. mixed), and study type (case–control vs. cohort vs. cross-sectional). We used precision-weighted mixed-effects meta-regressions to assess the potential effects of the continuous variables sex (percentage of women within samples) and publication year.
2.7 Publication bias
To detect potential influences of confounding dissemination bias, we used several different bias detection approaches (i.e., visual funnel plot inspection, formal funnel plot asymmetry-based assessments, selection model assessments, and p-value-based methods), following current recommendations (Siegel et al., 2022). First, we visually inspected funnel plots for potential asymmetry. Second, Sterne and Egger’s regression test (Egger et al., 1997) and Trim-and-Fill (Duval and Tweedie, 2000) were applied. The Sterne and Egger regression regresses effect standard deviates (i.e., standardized effects) on study precision. A significant intercept can be interpreted as evidence of publication bias. In Trim-and-Fill, funnel plot asymmetry is assessed and excessive effects in terms of strength according to the estimated summary effect are trimmed. Subsequently, the summary effect is re-estimated according to the trimmed data set. This iterative procedure is repeated until no further asymmetry is detected. Then, trimmed studies are reinserted, and presumably missing effects are symmetrically imputed on the opposite side of the funnel. Notably, the resulting adjusted effect size should not be seen as a corrected estimate but should be rather interpreted in the sense of a sensitivity analysis.
Third, we examined the effects of a moderate one-tailed selection based on Vevea and Woods (2005) selection model approach. In this method, effect sizes are weighted according to the publication likelihood of specific assumed p-values (we followed a standard weighting scenario as suggested by the authors). Their distribution is then compared to an unweighted model. The resulting effect estimates should be similar in the absence of publication bias.
Finally, we used p-uniform (Van Assen et al., 2015) and p-curve (Simonsohn et al., 2014) to assess potential bias. Both methods are based on the idea that study p-values are uniformly distributed in the presence of a null effect. With increasing non-null effect strength, the p-value distribution becomes increasingly right-skewed. An identical phenomenon should be observable when focusing exclusively on p-values that fall below the typically assumed significance threshold of 0.05. In p-curve, formal tests allow an assessment (i) of the evidential value of a given set of study effects as well as (ii) effect-distorting effects of p-hacking (i.e., extensive use of questionable research practices) based on the observed p-value distributions.
In p-uniform, conditional distributions of significant p-values based on the corresponding population effect size are compared with a uniform distribution to assess evidence for p-hacking. Moreover, this approach allows a summary effect and confidence interval estimation based only on the observed significant p-values and their associated degrees of freedom. Following current recommendations, we interpreted p-values <0.10 or differences between estimated effects exceeding 20% as indicative of publication bias in all detection methods (Siegel et al., 2022).
2.8 Final sample
We included 22 studies comprising k = 27 independent effect sizes (N = 11,452 patients; mean sample age = 39.5 years). Most participants were schizophrenic spectrum (n = 4,797) and bipolar spectrum patients (n = 4,020), with the remaining samples comprising both diagnosis types (n = 2,635). The majority of samples comprised outpatients (n = 6,269), with the remaining samples consisting of inpatients (n = 2,566) and mixed patient groups (n = 2,590). Primary study characteristics are detailed in Table 1.
Table 1
| Study (year) | N | Smokers | Non-smokers | OR | LBCI | UBCI | Study type | Diagnosis type | Mean age | % Women | Sample type | Country | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Suicide attempts | No suicide attempts | Suicide attempts | No suicide attempts | |||||||||||
| Altamura et al. (2003) | 103 | 20 | 54 | 2 | 27 | – | – | – | Cohort | SCZ | 39.1 | 33.98 | Out | Italy |
| Jarbin et al. (2004) | 41 | 8 | 10 | 2 | 21 | – | – | – | Cohort | SCZ | 37.1 | 46.34 | Out | Sweden |
| Jarbin et al. (2004) | 33 | 4 | 4 | 4 | 21 | – | – | – | Cohort | BP | 37.1 | 57.58 | Out | Sweden |
| Ostacher et al. (2006) | 399 | – | – | – | – | 2.74 | 1.77 | 4.23 | Cohort | BP | 38.6 | 54.14 | In | United States |
| Iancu et al. (2006) | 61 | 21 | 16 | 11 | 13 | – | – | – | Case | SCZ | 41.2 | 40.98 | Mx | Israel |
| Altamura et al. (2007) | 400 | 262 | 22 | 97 | 19 | – | – | – | Cross | SCZ | 37.2 | 30.5 | Out | United States and Canada |
| Altamura et al. (2007) | 232 | 131 | 38 | 41 | 22 | – | – | – | Cross | SCZ | 36.4 | 39.23 | Out | France, Italy, United Kingdom |
| Altamura et al. (2007) | 198 | 96 | 19 | 60 | 23 | – | – | – | Cross | SCZ | 38.1 | 53.03 | Out | Czech, Hungary, Croatia |
| Altamura et al. (2007) | 37 | 20 | 4 | 11 | 2 | – | – | – | Cross | SCZ | 35.3 | 37.84 | Out | South Africa |
| Altamura et al. (2007) | 93 | 57 | 6 | 25 | 5 | – | – | – | Cross | SCZ | 36.7 | 41.94 | Out | Argentina and Chile |
| Baethge et al. (2009) | 352 | 44 | 116 | 30 | 162 | – | – | – | Cohort | BP | 27.7 | 50.85 | Out | Italy |
| Ostacher et al. (2009) | 116 | 5 | 26 | 3 | 82 | – | – | – | Cohort | BP | 42 | 60.34 | Out | United States |
| Andriopoulos et al. (2011) | 106 | 8 | 71 | 0 | 27 | – | – | – | Case | SCZ | 27.9 | 30.19 | Out | Greece |
| Kao et al. (2011) | 95 | 40 | 22 | 13 | 20 | – | – | – | Cross | SCZ | 40.1 | 52.63 | Out | Taiwan |
| Gutiérrez-Rojas et al. (2012) | 108 | – | – | – | – | 5.4 | 1.9 | 15.5 | Cross | BP | – | – | Out | Spain |
| Baek et al. (2013) | 1,643 | 195 | 530 | 167 | 751 | – | – | – | Cross | BP | 40.2 | 68.65 | Out | United States |
| Kanwar et al. (2013) | 790 | – | – | – | – | 1.53 | 1.11 | 2.11 | Cross | SCZ | – | – | Mx | Germany |
| Sankaranarayanan et al. (2014) | 1,812 | 628 | 579 | 276 | 329 | – | – | – | Cross | MX | 38.4 | 40.51 | Out | Australia |
| Ducasse et al. (2015) | 453 | 88 | 104 | 91 | 170 | – | – | – | Cross | BP | 42.3 | 56.07 | Out | France |
| Antypa et al. (2016) | 553 | 133 | 173 | 80 | 167 | – | – | – | Cross | MX | 47.4 | 61.84 | Mx | Belgium |
| Xia et al. (2018) | 300 | 13 | 47 | 25 | 215 | – | – | – | Case | SCZ | 28.3 | 61.33 | In | China |
| Dickerson et al. (2019) | 270 | 77 | 40 | 79 | 74 | – | – | – | Cross | MX | 38.7 | 46.3 | Mx | United States |
| Icick et al. (2019) | 916 | 150 | 247 | 188 | 331 | – | – | – | Case | BP | 40.7 | 59.17 | Mx | Norway and France |
| Mallet et al. (2019) | 474 | 18 | 241 | 9 | 206 | – | – | – | Cross | SCZ | 32.2 | 24.26 | Out | France |
| Dai et al. (2020) | 906 | 71 | 531 | 26 | 278 | – | – | – | Cross | SCZ | 46.4 | 18.32 | In | China |
| Liu et al. (2020) | 767 | 81 | 394 | 44 | 248 | – | – | – | Case | SCZ | – | 18.25 | In | China |
| Dai et al. (2021) | 194 | 15 | 82 | 13 | 84 | – | – | – | Cross | SCZ | 46.5 | 0 | In | China |
Characteristics of included studies according to published reports.
LBCI, Lower bound of 95% confidence interval; UBCI, Upper bound of 95% confidence interval; cohort, cohort study; cross, cross-sectional study; case, case–control study; SCZ, patients with schizophrenia; BP, patients with bipolar disorder; MX, mixed patient groups; in, inpatients; out, outpatients; mx, mixed sample of in-and outpatients; references of included studies are available at https://osf.io/beh54.
3 Results
We observed a small association between smoking and lifetime suicide attempts, indicating larger odds of smokers than non-smokers of lifetime suicide attempts (OR = 1.70, 95% CI [1.48; 1.95], p < 0.001; Figure 2). There was some evidence for non-trivial, albeit small-to-moderate, between-studies heterogeneity (I2 = 40.28), which indicates effects of moderating variables as a source of the observed differences.
Figure 2
Therefore, we repeated our analyses while excluding two studies that had categorized smokers vs. non-smokers in a different manner than the remaining studies (i.e., most studies categorized past smokers into the non-smoker group while (Ostacher et al., 2006; Icick et al., 2019) categorized them as smokers). However, results were virtually identical, indicating no substantial effect of differing group assignments within primary studies on summary effect estimation (OR = 1.65, 95% CI [1.46; 1.85], p < 0.001). We, therefore, report all subsequent findings based on all k = 27 available independent effect sizes (numerical outcomes of these analyses for the subset of k = 25 effect sizes were virtually identical).
3.1 Subgroup analyses
Effect sizes were differentiated according to study type (Q = 12.141, p < 0.001), with cohort studies yielding a moderate effect (OR = 2.76, p < 0.001) that was significantly larger than effects from cross-sectional (OR = 1.58, p < 0.001) and case–control studies (OR = 1.28, p = 0.106).
Groups with different diagnoses showed predominantly small non-trivial effects that did not significantly differ between groups (Q = 0.864, p = 0.353). However, patients with bipolar disorder showed the numerically largest and non-trivial effect (OR = 2.02, p < 0.001), followed by patients with psychosis (OR = 1.64, p < 0.001), and the mixed group (OR = 1.44, p < 0.001).
Similarly, no significant differences between sample types were observed (Q = 1.614, p = 0.204), yielding mostly non-trivial but small effects. The outpatient group showed numerically somewhat larger effects (OR = 1.92, p < 0.001) compared to the inpatient (OR = 1.67, p = 0.008) and the mixed groups (OR = 1.42, p = 0.002). Numerical results of subgroup summary effects are detailed in Table 2.
Table 2
| OR | LBCI | UBCI | p | I2 | |
|---|---|---|---|---|---|
| Overall sample | |||||
| All (k = 27) | 1.70 | 1.48 | 1.95 | <0.001 | 40.28% |
| Diagnosis type | |||||
| SCZ (k = 16) | 1.64 | 1.39 | 1.94 | <0.001 | 0.83% |
| BP (k = 8) | 2.02 | 1.42 | 2.88 | <0.001 | 76.05% |
| Mixed (k = 3) | 1.44 | 1.18 | 1.75 | <0.001 | 21.11% |
| Sample type | |||||
| Inpatients (k = 5) | 1.67 | 1.15 | 2.42 | 0.008 | 58.98% |
| Outpatients (k = 17) | 1.92 | 1.56 | 2.34 | <0.001 | 36.79% |
| Mixed (k = 5) | 1.42 | 1.13 | 1.78 | 0.002 | 38.57% |
| Study type | |||||
| Cohort (k = 6) | 2.76 | 2.03 | 3.76 | <0.001 | <0.01% |
| Cross-sectional (k = 16) | 1.58 | 1.41 | 1.78 | <0.001 | 8.69% |
| Case–control (k = 5) | 1.28 | 0.95 | 1.71 | 0.106 | 26.55% |
Overall and subgroup-specific summary effects.
LBCI, Lower bound of 95% confidence interval; UBCI, Upper bound of 95% confidence interval; SCZ, patients with schizophrenia; BP, patients with bipolar disorder; I2, true heterogeneity/total observed variation.
3.2 Meta-regressions
A precision-weighted meta-regression of publication year on effect sizes indicated significant decreases in effect strength over time (b = −0.097, Q = 17.61, p < 0.001; Figure 3). Cumulative meta-analyses supported this finding, indicating almost exclusively continuously decreasing summary effect size estimates when individual study effects were added in turn according to study publication years (Figure 4).
Figure 3
Figure 4
In another meta-regression, the percentage of women within samples showed no significant influences on effect sizes (b = 0.004, Q = 1.05, p = 0.305; see Figure 5).
Figure 5
3.3 Publication bias
Visual inspection of the funnel plot showed substantial asymmetry, suggesting inflation of the observed summary effect (Figure 6). Formal tests in terms of Sterne and Egger’s regression method yielded significant results, thus supporting this interpretation (Z = 3.81, p < 0.001). Results from Trim-and-Fill were consistent with findings from Sterne and Egger’s regression, indicating nine missing effect sizes on the left side of the funnel plot and yielding an adjusted effect of OR = 1.51 (LogOR = 0.42).
Figure 6
In contrast, the selection model approach did not show evidence for publication bias, indicating an adjusted summary effect that remained within 20% of the value of the observed effect (i.e., OR = 1.69 vs. 1.70, respectively).
There was no significant evidence for p-hacking according to p-curve analysis in binomial and continuous tests. Moreover, both binomial and continuous tests indicated evidence for an appropriate evidential value of our summary effect calculations (see Figure 7). Similarly, p-uniform did not yield evidence for p-hacking either (p = 0.989). p-uniform-based summary effect estimations showed a non-trivial effect, yielding an OR = 1.63 (95% CI [1.52; 1.75], p < 0.001).
Figure 7
4 Discussion
In the present meta-analysis, we show a small but meaningful association between smoking and suicide attempts in patients with psychosis and bipolar disorder, indicating larger numbers of lifetime suicide attempts of smoking compared to non-smoking patients. This is important because these findings may contribute to identifying at-risk groups in terms of suicide in mentally ill individuals.
The observed smoking and suicide attempt link generalized over different types of diagnoses (psychosis and bipolar disorder), sample types (in-and outpatients), and participant sex but was differentiated according to study type (i.e., cohort vs. cross-sectional and case–control studies). However, the observed association appears confounded by dissemination bias and shows cross-temporal effect declines, thus indicating that our observed summary effect may be somewhat inflated. Our findings present several points of interest, as we discuss below.
First, in line with a previous meta-analysis (Sankaranarayanan et al., 2015), a patient’s diagnostic group (psychosis vs. bipolar spectrum) did not seem to influence the association between smoking and lifetime suicide attempts. This observed generalizing effect seems plausible because psychosis and bipolar disorder patient groups share comparable (elevated) smoking rates (Dickerson et al., 2013), neurological pathway processing (Kraguljac et al., 2012), and lifetime suicide prevalence (Gonda et al., 2012; Siris, 2001) that differ significantly from general population observations.
However, in contrast to previous findings (Sankaranarayanan et al., 2015), effects appeared to be differentiated according to study type, yielding stronger effects for cohort compared to cross-sectional or case–control studies. Because prospective cohort studies epistemologically offer the most rigorous approach in observational studies (Mann, 2003), this may be interpreted as tentative evidence for effect underestimations in cross-sectional and case–control studies. However, in light of the comparatively small number of included studies, potential alternative reasons for effect differentiation cannot be entirely ruled out.
Second, sample type (in-vs. outpatients) did not significantly influence the observed summary effect. This is somewhat unexpected because being less monitored by potentially aiding and intervening health professionals, especially in the first year of discharge, could arguably be expected to increased suicide attempt prevalence (Chung et al., 2017; Olfson et al., 2016). The more substantial relationship between healthcare satisfaction and subjective quality of life compared to inpatients (Petkari and Pietschnig, 2015) has led researchers to argue that outpatients may be at higher risk of attempting suicide than inpatients. In contrast, other researchers have argued that inpatients might be more prone to attempting suicide due to more severe symptoms, which are the cause for their hospitalization (Bostwick and Pankratz, 2000; Zaheer et al., 2018), as opposed to the protective effects of living independently (Cassidy et al., 2018). In any case, our empirical evidence shows that smoking status and suicide attempt correlations do not appear to be differentiated according to being taken care of in inpatient compared to outpatient settings.
Third, effects generalized across sex, indicating no meaningful influences of sex-specific suicide attempt prevalence with respect to smoking status. This is interesting because women typically show higher depression and suicide attempt prevalence than men, although men typically show a higher prevalence of completed suicides in the general population (Tsirigotis et al., 2011; Värnik, 2012). A similar pattern has been observed in psychotic patients, with women showing larger prevalences of depression and suicide attempts than men (Värnik, 2012; Austad et al., 2015) and men showing a higher prevalence in terms of completed suicides than women (Bertelsen et al., 2007; Healy et al., 2012), although not all patient-based studies were consistent with these results (Lester, 2006; Carlborg et al., 2008). Our results contrast prior findings of differentiated smoking effects on suicide attempts between men and women in young adults of the US general population that indicated positive associations in men, but no effects in women (Zhang et al., 2005). This indicates that smoking status may be useful to identify at-risk groups regardless of patient sex.
Finally, we observed a cross-temporal decline in terms of effect sizes, indicating stronger effects of studies that had been published in earlier years. On the one hand, it is possible that smoking status and suicide attempt associations have genuinely changed in the past decades, conceivably owing to decreasing global smoking [e.g., decreasing sales of cigarettes per adult per day (Forey et al., 2016)] or suicide attempt prevalence (e.g., Xiao et al., 2021, for US data). On the other hand, this observation can be plausibly attributed to the so-called decline effect [i.e., inflated effect sizes having a larger probability of being published earlier which leads to an inflated perception of the true effect in the published scientific literature; (Pietschnig et al., 2019)], thus representing a publication mechanism-related phenomenon that leads to (non-genuine) inflated effects in the published literature. This latter interpretation is supported by evidence for publication bias in funnel-plot asymmetry-based detection methods, which was observed in our present analyses. The presently observed small non-trivial summary effect may thus be considered to represent an upper threshold of the true effect of smoking status and suicide attempt associations in individuals with psychosis and bipolar disorder.
4.1 Limitations
Some limitations of this meta-analysis need to be acknowledged. First, due to the correlational design of the present study, it was not possible to empirically establish a causal mechanism in regard to the smoking status and suicide attempt link of individuals with psychosis and bipolar disorder. However, the observed non-trivial link provides a useful means for practical care recommendations. Second, some statistical noise may have been introduced by different design characteristics between primary studies that could not be entirely accounted for in our present meta-analysis (e.g., in terms of different smoking operationalizations or psychosis and bipolar disorder assessments). However, this is common in meta-analytical investigations and was accounted for by modeling between-studies heterogeneity in terms of random-effects calculations. Finally, self-reports of lifetime suicide attempts are susceptible to misclassification (Castelein et al., 2015) and prone to survival bias (only reports by survivors). Nonetheless, suicide attempts have been frequently been observed to predict suicide better than suicide ideation (Millner et al., 2015; May and Klonsky, 2016; Ribeiro et al., 2016). There is no reason to suspect that any of these points may have introduced any systematic influences on summary effect estimations, thus providing evidence for the salience of our observed summary effect.
5 Conclusion
Here, we show evidence for a non-trivial association between smoking status and lifetime suicide attempts in individuals with psychosis and bipolar disorder. Smoking patients self-reported significantly larger numbers of lifetime suicide attempts than non-smoking patients, regardless of diagnosis type (i.e., psychosis vs. bipolar spectrum), sample type (i.e., in-vs. outpatients), or sex. This link appears to be small but meaningful, thus suggesting that smoking status represents a useful variable for the identification of at-risk populations for suicide attempts in psychotic patients.
Statements
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.
Author contributions
JP: Conceptualization, Formal analysis, Methodology, Supervision, Visualization, Writing – original draft, Writing – review & editing. SO: Formal analysis, Visualization, Writing – original draft, Writing – review & editing. MK: Data curation, Formal analysis, Methodology, Visualization, Writing – original draft, Writing – review & editing.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Open Access Funding provided by the University of Vienna.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Footnotes
References
1
AltamuraA. C.BassettiR.BignottiS.PioliR.MundoE. (2003). Clinical variables related to suicide attempts in schizophrenic patients: A retrospective study. Schizophrenia Res.60, 47–55. doi: 10.1016/S0920-9964(02)00164-0
2
AltamuraA. C.MundoE.BassettiR.GreenA.LindenmayerJ. P.AlphsL.et al. (2007). Transcultural differences in suicide attempters: Analysis on a highrisk population of patients with schizophrenia or schizoaffective disorder. Schizophrenia Res.89, 140–146. doi: 10.1016/j.schres.2006.08.023
3
AndriopoulosI.EllulJ.SkokouM.BeratisS. (2011). Suicidality in the “prodromal”phase of schizophrenia. Compr. Psychiatry52, 479–485. doi: 10.1016/j.comppsych.2010.10.011
4
AntypaN.SoueryD.TomasiniM.AlbaniD.FuscoF.MendlewiczJ. (2016). Clinical and genetic factors associated with suicide in mood disorder patients. Eur Arch Psychiatry Clin Neurosci.266, 181–193. doi: 10.1007/s00406-015-0658-1
5
AustadG.JoaI.JohannessenJ. O.LarsenT. K. (2015). Gender differences in suicidal behaviour in patients with first-episode psychosis. Early Interv. Psychiatry9, 300–307. doi: 10.1111/eip.12113
6
BaekJ. H.EisnerL. R.NierenbergA. A. (2013). Smoking and suicidality in subjects with bipolar disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Depression and Anxiety30, 982–990. doi: 10.1002/da.22107
7
BaethgeC.TondoL.LepriB.BaldessariniR. J. (2009). Coffee and cigarette use: Association with suicidal acts in 352 Sardinian bipolar disorder patients. Bipolar Disord.11, 494–503. doi: 10.1111/j.1399-5618.2009.00727.x
8
BertelsenM.JeppesenP. I.PetersenL.ThorupA.Le QuachP.ChristensenT. Ø.et al. (2007). Suicidal behaviour and mortality in first-episode psychosis: the OPUS trial. Br. J. Psychiatry191, s140–s146. doi: 10.1192/bjp.191.51.s140
9
BoraE.YucelM.PantelisC. (2009). Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: Meta-analytic study. Br. J. Psychiatry195, 475–482. doi: 10.1192/bjp.bp.108.055731
10
BostwickJ. M.PankratzV. S. (2000). Affective disorders and suicide risk: a reexamination. Am. J. Psychiatry157, 1925–1932. doi: 10.1176/appi.ajp.157.12.1925
11
CarlborgA.JokinenJ.JönssonE. G.NordströmA. L.NordströmP. (2008). Long-term suicide risk in schizophrenia spectrum psychoses: survival analysis by gender. Arch. Suicide Res.12, 347–351. doi: 10.1080/13811110802325133
12
CassidyR. M.YangF.KapczinskiF.PassosI. C. (2018). Risk factors for suicidality in patients with schizophrenia: a systematic review, meta-analysis, and meta-regression of 96 studies. Schizophr. Bull.44, 787–797. doi: 10.1093/schbul/sbx131
13
CasteleinS.LiemburgE. J.de LangeJ. S.van EsF. D.VisserE.AlemanA.et al. (2015). Suicide in recent onset psychosis revisited: significant reduction of suicide rate over the last two decades—a replication study of a Dutch incidence cohort. PLoS One10:e0129263. doi: 10.1371/journal.pone.0129263
14
ChungD. T.RyanC. J.Hadzi-PavlovicD.SinghS. P.StantonC.LargeM. M. (2017). Suicide rates after discharge from psychiatric facilities: a systematic review and meta-analysis. JAMA Psychiatry74, 694–702. doi: 10.1001/jamapsychiatry.2017.1044
15
CoburnK. M.VeveaJ. L.CoburnM. K. (2019). Package ‘weightr’. Estimating weight-function models for publication bias.
16
CohenJ. (1988). Statistical power analysis for the behavioral sciences. 2nd Edn. Mahwah, NJ: L. Erlbaum Associates.
17
DaiQ.WangD.WangJ.XuH.AndriescueE. C.WuH. E. (2020). Suicide attempts in Chinese Han patients with schizophrenia: Cognitive, demographic, and clinical variables. Braz. J. Psychiatry.43, 29–34. doi: 10.1590/1516-4446-2020-0900
18
DaiQ.ZhouY.LiuY.WeiS.ZhouH.TianY.et al. (2021). Alcohol use history increases the likelihood of suicide behavior among male chronic patients with schizophrenia in a Chinese population. Suicide Life Threat Behav.52, 716–724. doi: 10.1111/sltb.12855
19
de BeaurepaireR.RatP.BeauverieP.HoueryM.NielP.CastéraS.et al. (2012). Is smoking linked to positive symptoms in acutely ill psychiatric patients?Nord. J. Psychiatry66, 225–231. doi: 10.3109/08039488.2011.610468
20
DickersonF.StallingsC. R.OrigoniA. E.VaughanC.KhushalaniS.SchroederJ.et al. (2013). Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999-2011. Psychiatr. Serv.64, 44–50. doi: 10.1176/appi.ps.201200143
21
DickersonF.StallingsC.OrigoniA.KatsafanasE.SweeneyK.KhushalaniS. (2019). Nitrated meat products are associated with suicide behavior in psychiatric patients. Psychiatry Research275, 283–286. doi: 10.1016/j.psychres.2019.03.047
22
DowleM.SrinivasanA.GoreckiJ.ChiricoM.StetsenkoP.ShortT.et al. (2019). Package ‘data. table’. Extension of ‘data. frames.
23
DucasseD.JaussentI.GuillaumeS.AzorinJ. M.BellivierF.BelzeauxR.et al. (2015). Increased risk of suicide attempt in bipolar patients with severe tobacco dependence. J. Affect. Disord.183, 113–118. doi: 10.1016/j.jad.2015.04.038
24
DürlingerF.PietschnigJ. (2022). Meta-analyzing intelligence and religiosity associations: evidence from the multiverse. PLoS One17:e0262699. doi: 10.1371/journal.pone.0262699
25
DuvalS.TweedieR. (2000). A nonparametric “trim and fill” method of accounting for publication bias in meta-analysis. J. Am. Stat. Assoc.95, 89–98. doi: 10.1080/01621459.2000.10473905
26
EggerM.SmithG. D.SchneiderM.MinderC. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ315, 629–634. doi: 10.1136/bmj.315.7109.629
27
ForeyB.HamlingJ.LeeP.WaldN. (2016). International smoking statistics: WEB edition. Sutton: P. N. Lee Statistics and Computing Ltd.
28
GilS. M.MetherateR. (2019). Enhanced sensory-cognitive processing by activation of nicotinic acetylcholine receptors. Nicotine Tob. Res.21, 377–382. doi: 10.1093/ntr/nty134
29
GondaX.PompiliM.SerafiniG.MonteboviF.CampiS.DomeP.et al. (2012). Suicidal behavior in bipolar disorder: epidemiology, characteristics and major risk factors. J. Affect. Disord.143, 16–26. doi: 10.1016/j.jad.2012.04.041
30
GreenM. F.HoranW. P.LeeJ. (2015). Social cognition in schizophrenia. Nat. Rev. Neurosci.16, 620–631. doi: 10.1038/nrn4005
31
GurilloP.JauharS.MurrayR. M.Mac CabeJ. H. (2015). Does tobacco use cause psychosis? Systematic review and meta-analysis. Lancet Psychiatry2, 718–725. doi: 10.1016/S2215-0366(15)00152-2
32
Gutiérrez-RojasL.GurpeguiM.SotoF.Martínez-OrtegaJ.JuradoL. (2012). High nicotine dependence is a factor in the risk of suicide in bipolar disorder patients: Int. Clin. Psychopharmacol.28, e18–e19. doi: 10.1097/01.yic.0000423262.48950.39
33
HartzS. M.PatoC. N.MedeirosH.Cavazos-RehgP.SobellJ. L.KnowlesJ. A.et al. (2014). Comorbidity of severe psychotic disorders with measures of substance use. JAMA. Psychiatry71, 248–254. doi: 10.1001/jamapsychiatry.2013.3726
34
HausteinK. O.HaffnerS.WoodcockB. G. (2002). A review of the pharmacological and psychopharmacological aspects of smoking and smoking cessation in psychiatric patients. Int. J. Clin. Pharmacol. Ther.40, 404–418. doi: 10.5414/CPP40404
35
HealyD.Le NouryJ.HarrisM.ButtM.LindenS.WhitakerC.et al. (2012). Mortality in schizophrenia and related psychoses: data from two cohorts, 1875-1924 and 1994-2010. BMJ Open2:e001810. doi: 10.1136/bmjopen-2012-001810
36
HigginsJ. P.ThompsonS. G.DeeksJ. J.AltmanD. G. (2003). Measuring inconsistency in meta-analyses. BMJ327, 557–560. doi: 10.1136/bmj.327.7414.557
37
IancuI.SapirA. P.ShakedG.PorehA.DannonP. N.ChelbenJ.et al. (2006). Increased Suicidal Risk Among Smoking Schizophrenia Patients. Clin. Neuropharmacol.29, 230–237. doi: 10.1097/01.WNF.0000228178.75711.EB
38
IcickR.MelleI.EtainB.RingenP. A.AminoffS. R.LeboyerM.et al. (2019). Tobacco smoking and other substance use disorders associated with recurrent suicide attempts in bipolar disorder. J. Affect. Disord.256, 348–357. doi: 10.1016/j.jad.2019.05.075
39
IsuruA.RajasuriyaM. (2019). Tobacco smoking and schizophrenia: re-examining the evidence. BJPsych. Adv.25, 363–372. doi: 10.1192/bja.2019.33
40
JarbinH.von KnorringA.-L. (2004). Suicide and suicide attempts in adolescent-onset psychotic disorders. Nord. J. Psychiatry58, 115–123. doi: 10.1080/08039480410005611
41
KanwarJ.OkusagaO.GieglingI.KonteB.VaswaniD.SleemiA.et al. (2013). In patients with schizophrenia, non-fatal suicidal selfdirected violence is positively associated with present but not past smoking. Schizophr. Res.149, 194–195. doi: 10.1016/j.schres.2013.06.010
42
KaoY.-C.LiuY.-P.ChengT.-H.ChouM.-K. (2011). Cigarette smoking in outpatients with chronic schizophrenia in Taiwan: Relationships to socio-demographic and clinical characteristics. Psychiatry Res.190, 193–199. doi: 10.1016/j.psychres.2011.05.016
43
KhokharJ. Y.DwielL. L.HenricksA. M.DoucetteW. T.GreenA. I. (2018). The link between schizophrenia and substance use disorder: a unifying hypothesis. Schizophr. Res.194, 78–85. doi: 10.1016/j.schres.2017.04.016
44
KnappF.ViechtbauerW.LeonhartR.NitschkeK.KallerC. P. (2017). Planning performance in schizophrenia patients: a meta-analysis of the influence of task difficulty and clinical and sociodemographic variables. Psychol. Med.47, 2002–2016. doi: 10.1017/S0033291717000459
45
KraguljacN. V.ReidM.WhiteD.JonesR.den HollanderJ.LowmanD.et al. (2012). Neurometabolites in schizophrenia and bipolar disorder—a systematic review and meta-analysis. Psychiatry Res. Neuroimaging203, 111–125. doi: 10.1016/j.pscychresns.2012.02.003
46
KumariV.PostmaP. (2005). Nicotine use in schizophrenia: the self-medication hypotheses. Neurosci. Biobehav. Rev.29, 1021–1034. doi: 10.1016/j.neubiorev.2005.02.006
47
LeeP.Van MeterA. (2020). Emotional body language: social cognition deficits in bipolar disorder. J. Affect. Disord.272, 231–238. doi: 10.1016/j.jad.2020.03.114
48
LesterD. (2006). Sex differences in completed suicide by schizophrenic patients: a meta-analysis. Suicide Life Threat. Behav.36, 50–56. doi: 10.1521/suli.2006.36.1.50
49
LiuJ. H.ZhuC.ZhengK.TangW.GaoL. L.TrihnT. H.et al. (2020). MTHFR Ala222Val polymorphism and clinical characteristics confer susceptibility to suicide attempt in chronic patients with schizophrenia. Scientific Reports10:5008. doi: 10.1038/s41598-020-57411-1
50
LüdeckeD.LüdeckeM. D.DavidB. W. (2019). Package ‘esc’. R Package Version 0.5.2019.
51
MalletJ.StratJ. L.SchürhoffF.MazerN.PortalierC.AndrianarisoaM.et al. (2019). Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort. Eur Arch Psychiatry Clin Neurosci.269, 449–457. doi: 10.1007/s00406-018-0873-7
52
MannC. J. (2003). Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg. Med. J.20, 54–60. doi: 10.1136/emj.20.1.54
53
MartinL. M.SayetteM. A. (2018). A review of the effects of nicotine on social functioning. Exp. Clin. Psychopharmacol.26, 425–439. doi: 10.1037/pha0000208
54
MayA. M.KlonskyE. D. (2016). What distinguishes suicide attempters from suicide ideators? A meta-analysis of potential factors. Clin. Psychol. Sci. Pract.23, 5–20. doi: 10.1111/cpsp.12136
55
MillnerA. J.LeeM. D.NockM. K. (2015). Single-item measurement of suicidal behaviors: validity and consequences of misclassification. PLoS One10:e0141606. doi: 10.1371/journal.pone.0141606
56
MiskowiakK. W.SeebergI.KjaerstadH. L.BurdickK. E.Martinez-AranA.del MarB. C.et al. (2019). Affective cognition in bipolar disorder: a systematic review by the ISBD targeting cognition task force. Bipolar Disord.21, 686–719. doi: 10.1111/bdi.12834
57
OlfsonM.WallM.WangS.CrystalS.LiuS. M.GerhardT.et al. (2016). Short-term suicide risk after psychiatric hospital discharge. JAMA Psychiatry73, 1119–1126. doi: 10.1001/jamapsychiatry.2016.2035
58
OstacherM. J.NierenbergA. A.PerlisR. H.EidelmanP.BorrelliD. J.TranT. B.et al. (2006). The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. J. Clin. Psychiatry67, 1907–1911. doi: 10.4088/JCP.v67n1210
59
OstacherM. J.LeBeauR. T.PerlisR. H.NierenbergA. A.LundH. G.MoshierS. J.et al. (2009). Cigarette smoking is associated with suicidality in bipolar disorder. Bipolar Disord.11, 766–771. doi: 10.1111/j.1399-5618.2009.00744.x
60
PetkariE.PietschnigJ. (2015). Associations of quality of life with service satisfaction in psychotic patients: a meta-analysis. PLoS One10:e0135267. doi: 10.1371/journal.pone.0135267
61
PietschnigJ.SiegelM.EderJ. S.GittlerG. (2019). Effect declines are systematic, strong, and ubiquitous: a meta-meta-analysis of the decline effect in intelligence research. Front. Psychol.10:2874. doi: 10.3389/fpsyg.2019.02874
62
PompiliM.GondaX.SerafiniG.InnamoratiM.SherL.AmoreM.et al. (2013). Epidemiology of suicide in bipolar disorders: a systematic review of the literature. Bipolar Disord.15, 457–490. doi: 10.1111/bdi.12087
63
R Core Team (2023). R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing.
64
RibeiroJ. D.FranklinJ. C.FoxK. R.BentleyK. H.KleimanE. M.ChangB. P.et al. (2016). Self-injurious thoughts and behaviors as risk factors for future suicide ideation, attempts, and death: a meta-analysis of longitudinal studies. Psychol. Med.46, 225–236. doi: 10.1017/S0033291715001804
65
SankaranarayananA.MancusoS.CastleD. (2014). Smoking and suicidality in patients with a psychotic disorder. Psychiatry Res.215, 634–640. doi: 10.1016/j.psychres.2013.12.032
66
SankaranarayananA.MancusoS.WildingH.GhuloumS.CastleD. (2015). Smoking, suicidality and psychosis: a systematic meta-analysis. PLoS One10:e0138147. doi: 10.1371/journal.pone.0138147
67
SavlaG. N.VellaL.ArmstrongC. C.PennD. L.TwamleyE. W. (2013). Deficits in domains of social cognition in schizophrenia: a meta-analysis of the empirical evidence. Schizophr. Bull.39, 979–992. doi: 10.1093/schbul/sbs080
68
SiegelM.EderJ. S.WichertsJ. M.PietschnigJ. (2022). Times are changing, bias isn’t: a meta-meta-analysis on publication bias detection practices, prevalence rates, and predictors in industrial/organizational psychology. J. Appl. Psychol.107, 2013–2039. doi: 10.1037/apl0000991
69
SimonsohnU.NelsonL. D.SimmonsJ. P. (2014). P-curve and effect size: correcting for publication bias using only significant results. Perspect. Psychol. Sci.9, 666–681. doi: 10.1177/1745691614553988
70
SirisS. G. (2001). Suicide and schizophrenia. J. Psychopharmacol.15, 127–135. doi: 10.1177/026988110101500209
71
TsirigotisK.GruszczynskiW.TsirigotisM. (2011). Gender differentiation in methods of suicide attempts. Medical science monitor: international medical journal of experimental and clinical. Research17, PH65–PH70. doi: 10.12659/MSM.881887
72
van AertR. C.van AertM. R.van AssenV. A. (2020). Package “puniform.”.
73
Van AssenM. A.van AertR.WichertsJ. M. (2015). Meta-analysis using effect size distributions of only statistically significant studies. Psychol. Methods20, 293–309. doi: 10.1037/met0000025
74
VärnikP. (2012). Suicide in the world. Int. J. Environ. Res. Public Health9, 760–771. doi: 10.3390/ijerph9030760
75
VeveaJ. L.WoodsC. M. (2005). Publication bias in research synthesis: sensitivity analysis using a priori weight functions. Psychol. Methods10, 428–443. doi: 10.1037/1082-989X.10.4.428
76
ViechtbauerW. (2010). Conducting meta-analyses in R with the metafor package. J. Stat. Softw.36, 1–48. doi: 10.18637/jss.v036.i03
77
WellsG. A.SheaB.O’ConnelD.PetersonJ.WelchV.LososM.et al. (2021). The Newcastle-Ottowa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottowa: Ottowa Hospital Research Institute.
78
WickhamH.BryanJ.KalicinskiM.ValeryK.LeitienneC.ColbertB.et al. (2019). Package ‘readxl’. Version, 1.3.
79
WickhamH.WickhamM. H. (2017). Package tidyverse. Easily install and load the ‘Tidyverse.
80
XiaH.ZhangG.DuX.ZhangY.YinG.DaiJ.et al. (2018). Suicide attempt, clinical correlates, and BDNF Val66Met polymorphism in chronic patients with schizophrenia. Neuropsychol.32, 199–205. doi: 10.1037/neu0000383
81
XiaoY.CerelJ.MannJ. J. (2021). Temporal trends in suicidal ideation and attempts among US adolescents by sex and race/ethnicity, 1991-2019. JAMA Netw. Open4:e2113513. doi: 10.1001/jamanetworkopen.2021.13513
82
ZaheerJ.JacobB.de OliveiraC.RudolerD.JudaA.KurdyakP. (2018). Service utilization and suicide among people with schizophrenia spectrum disorders. Schizophr. Res.202, 347–353. doi: 10.1016/j.schres.2018.06.025
83
ZhangJ.McKeownR. E.HusseyJ. R.ThompsonS. J.WoodsJ. R. (2005). Gender differences in risk factors for attempted suicide among young adults: findings from the third National Health and nutrition examination survey. Ann. Epidemiol.15, 167–174. doi: 10.1016/j.annepidem.2004.07.095
Summary
Keywords
smoking, suicide, meta-analysis, psychosis, quantitative review, bipolar disorder
Citation
Pietschnig J, Oberleiter S and Köhler MD (2024) Smoking behavior is associated with suicidality in individuals with psychosis and bipolar disorder: a systematic quantitative review and meta-analysis. Front. Psychol. 15:1369669. doi: 10.3389/fpsyg.2024.1369669
Received
15 January 2024
Accepted
03 September 2024
Published
12 September 2024
Volume
15 - 2024
Edited by
Sohrab Amiri, Baqiyatallah University of Medical Sciences, Iran
Reviewed by
Maxim Zavorotnyy, Psychiatric Services Aargau, Switzerland
Zi-yang Cui, Capital Medical University, China
Updates
Copyright
© 2024 Pietschnig, Oberleiter and Köhler.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jakob Pietschnig, jakob.pietschnig@univie.ac.at
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.